Conditional inactivation of Blimp1 in adult mice promotes increased bone mass

Journal of Biological Chemistry

Volumn 287, Issue 34, 2012, Pages 28508-28517

  Miyauchi, Yoshiteru ^a   Miyamoto, Hiroya ^a   Yoshidas, Shigeyuki ^a   Mori, Tomoaki ^a   Kanagawa, Hiroya ^a   Katsuyama, Eri ^a   Fujie, Atsuhiro ^a   Hao, Wu ^a   Hoshi, Hiroko ^a   Miyamoto, Kana ^a   Sato, Yuiko ^a   Kobayashi, Tami ^a   Akiyama, Haruhiko ^b   Morioka, Hideo ^a   Matsumoto, Morio ^a   Toyama, Yoshiaki ^a   Miyamoto, Takeshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT MICE; BONE LOSS; BONE MASS; BONE RESORPTION; DESTRUCTIVE DISEASE; EX-VIVO; FEMALE ADULTS; IMMUNE CELL DIFFERENTIATION; IMMUNE CELLS; IN-VIVO; MOLECULAR TARGETS; OSTEOCLAST DIFFERENTIATION; OSTEOCLAST FORMATION; OSTEOCLASTOGENESIS; POTENTIAL TARGETS;

BONE; TRANSCRIPTION FACTORS;

BALLOONS;

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MASS; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; BONE AND BONES; BONE RESORPTION; CELL DIFFERENTIATION; FEMALE; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; OSTEOCLASTS; TRANSCRIPTION FACTORS;

EID: 84865218471     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.356634     Document Type: Article

References (30)

1. Karsenty, G., and Wagner, E. F. (2002) Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406 (Pubitemid 34436569)
2. Rodan, G. A., and Martin, T. J. (2000) Therapeutic approaches to bone diseases. Science 289, 1508-1514
3. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., and Penninger, J. M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323
4. Nakashima, T., and Takayanagi, H. (2009) Osteoclasts and the immune system. J. Bone Miner. Metab. 27, 519-529
5. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y., and Suda, T. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202, 345-351 (Pubitemid 41126951)
6. Li, C. Y., Jepsen, K. J., Majeska, R. J., Zhang, J., Ni, R., Gelb, B. D., and Schaffler, M. B. (2006) Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J. Bone Miner. Res. 21, 865-875 (Pubitemid 43787993)
7. Miyauchi, Y., Ninomiya, K., Miyamoto, H., Sakamoto, A., Iwasaki, R., Hoshi, H., Miyamoto, K., Hao, W., Yoshida, S., Morioka, H., Chiba, K., Kato, S., Tokuhisa, T., Saitou, M., Toyama, Y., Suda, T., and Miyamoto, T. (2010) The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J. Exp. Med. 207, 751-762
8. Pasqualucci, L., Bereschenko, O., Niu, H., Klein, U., Basso, K., Guglielmino, R., Cattoretti, G., and Dalla-Favera, R. (2003) Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk. Lymphoma 44, S5-12
9. Nishikawa, K., Nakashima, T., Hayashi, M., Fukunaga, T., Kato, S., Kodama, T., Takahashi, S., Calame, K., and Takayanagi, H. (2010) Blimp1- mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl. Acad. Sci. U.S.A. 107, 3117-3122
10. Ohinata, Y., Payer, B., O'Carroll, D., Ancelin, K., Ono, Y., Sano, M., Barton, S. C., Obukhanych, T., Nussenzweig, M., Tarakhovsky, A., Saitou, M., and Surani, M. A. (2005) Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436, 207-213 (Pubitemid 41021265)
11. Shapiro-Shelef, M., Lin, K. I., McHeyzer-Williams, L. J., Liao, J., McHeyzer-Williams, M. G., and Calame, K. (2003) Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19, 607-620 (Pubitemid 37311441)
12. Martins, G. A., Cimmino, L., Shapiro-Shelef, M., Szabolcs, M., Herron, A., Magnusdottir, E., and Calame, K. (2006) Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat. Immunol. 7, 457-465
13. Kallies, A., Hawkins, E. D., Belz, G. T., Metcalf, D., Hommel, M., Corcoran, L. M., Hodgkin, P. D., and Nutt, S. L. (2006) Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat. Immunol. 7, 466-474
14. Kallies, A., Carotta, S., Huntington, N. D., Bernard, N. J., Tarlinton, D. M., Smyth, M. J., and Nutt, S. L. (2011) A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood 117, 1869-1879
15. Harper, J., Mould, A., Andrews, R. M., Bikoff, E. K., and Robertson, E. J. (2011) The transcriptional repressor Blimp1/Prdm1 regulates postnatal reprogramming of intestinal enterocytes. Proc. Natl. Acad. Sci. U.S.A. 108, 10585-10590
16. Muncan, V., Heijmans, J., Krasinski, S. D., Büller, N. V., Wildenberg, M. E., Meisner, S., Radonjic, M., Stapleton, K. A., Lamers, W. H., Biemond, I., van den Bergh Weerman, M. A., O'Carroll, D., Hardwick, J. C., Hommes, D. W., and van den Brink, G. R. (2011) Blimp1 regulates the transition of neonatal to adult intestinal epithelium. Nat. Commun. 2, 452-463
17. Robertson, E. J., Charatsi, I., Joyner, C. J., Koonce, C. H., Morgan, M., Islam, A., Paterson, C., Lejsek, E., Arnold, S. J., Kallies, A., Nutt, S. L., and Bikoff, E. K. (2007) Blimp1 regulates development of the posterior forelimb, caudal pharyngeal arches, heart and sensory vibrissae in mice. Development 134, 4335-4345
18. Nakanishi, R., Akiyama, H., Kimura, H., Otsuki, B., Shimizu, M., Tsuboyama, T., and Nakamura, T. (2008) Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. J. Bone Miner. Res. 23, 271-277 (Pubitemid 351160041)
19. Miyamoto, T., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M., and Suda, T. (2000) An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand. Blood 96, 4335-4343
20. Tohmonda, T., Miyauchi, Y., Ghosh, R., Yoda, M., Uchikawa, S., Takito, J., Morioka, H., Nakamura, M., Iwawaki, T., Chiba, K., Toyama, Y., Urano, F., and Horiuchi, K. (2011) The IRE1α-XBP1 pathway is essential for osteoblast differentiation through promoting transcription of Osterix. EMBO Rep. 12, 451-457
21. Hoelbl, A., Schuster, C., Kovacic, B., Zhu, B., Wickre, M., Hoelzl, M. A., Fajmann, S., Grebien, F., Warsch, W., Stengl, G., Hennighausen, L., Poli, V., Beug, H., Moriggl, R., and Sexl, V. (2010) Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. EMBO Mol. Med. 2, 98 -110
22. Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., Wagner, E. F., and Taniguchi, T. (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416, 744-749 (Pubitemid 34429151)
23. Ninomiya, K., Miyamoto, T., Imai, J., Fujita, N., Suzuki, T., Iwasaki, R., Yagi, M., Watanabe, S., Toyama, Y., and Suda, T. (2007) Osteoclastic activity induces osteomodulin expression in osteoblasts. Biochem. Biophys. Res. Commun. 362, 460-466 (Pubitemid 47332432)
24. Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., and Suda, T. (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J. Exp. Med. 190, 1741-1754 (Pubitemid 30013841)
25. Vincent, S. D., Dunn, N. R., Sciammas, R., Shapiro-Shalef, M., Davis, M. M., Calame, K., Bikoff, E. K., and Robertson, E. J. (2005) The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development 132, 1315-1325 (Pubitemid 40528791)
26. Bikoff, E. K., Morgan, M. A., and Robertson, E. J. (2009) An expanding job description for Blimp-1/PRDM1. Curr. Opin. Genet. Dev. 19, 379-385
27. Baron, R., Ferrari, S., and Russell, R. G. (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677-692
28. Furuya, Y., Mori, K., Ninomiya, T., Tomimori, Y., Tanaka, S., Takahashi, N., Udagawa, N., Uchida, K., and Yasuda, H. (2011) Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-κB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts. J. Biol. Chem. 286, 37023-37031
29. Tontonoz, P., and Spiegelman, B. M. (2008) Fat and beyond: the diverse biology of PPARγ. Annu. Rev. Biochem. 77, 289-312
30. Choi, J. H., Banks, A. S., Kamenecka, T. M., Busby, S. A., Chalmers, M. J., Kumar, N., Kuruvilla, D. S., Shin, Y., He, Y., Bruning, J. B., Marciano, D. P., Cameron, M. D., Laznik, D., Jurczak, M. J., Schürer, S. C., Vidović, D., Shulman, G. I., Spiegelman, B. M., and Griffin, P. R. (2011) Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation. Nature 477, 477-481